Supervisor Database Search

Guidance for ICAT Supervisors

The ICAT Supervisor list is reviewed annually by the partner universities and updated online in March/April each year.

You can read about the ICAT supervisor selection process and eligibility criteria below:

Terms of reference/guide to supervising ICAT Fellows.

You can read the terms of reference for supervisors actively supervising ICAT Fellows below:

Supervisor Database

Search for supervisors below. You can filter your search using the options and select multiple fields by holding CTRL (Cmd on Mac) + clicking multiple options in a list.

← Go back

Full NameProfessor David Finn

Pharmacology and Therapeutics; Galway Neuroscience Centre and Centre for Pain Research

University of Galway

Webpage:nuigalway.ie

Email hidden; Javascript is required.

Research Fields
  • physiology and non-communicable disease
  • neuroscience and mental health
  • bioengineering/medical devices
  • Other
Other Research Fields:

pain, stress, anxiety, depression, cognition, neurobiology, anesthesiology, inflammation, cannabinoids, opioids

Postgrad Medical Specialties
  • Medicine
  • Surgery
  • Psychiatry
  • Anaesthetics
  • Emergency Medicine
  • General Practice
  • Obstetrics and Gynaecology
  • Occupational Medicine
  • Sports and Exercise Medicine
Medical Subspecialties
  • Adolescent medicine
  • Child and Adolescent Psychiatry
  • Endocrinology
  • Geriatric Medicine
  • Neurology
  • Neurophysiology
  • Neuropsychiatry
  • Orthopaedic surgery
  • Pharmacology
  • Physiology
  • Rheumatology
My Work

Pain is the most common reason people see their doctor, with 20-30% of the population suffering from chronic pain. The overall objective of research in Professor Finn's laboratory is to increase understanding of the neurobiological mechanisms underlying the development and treatment of pain (acute and chronic), affective disorders (anxiety and depression), impaired cognition and their interaction/co-morbidity. The work is focused on a number of different endogenous signalling systems as potential therapeutic targets for these key unmet clinical needs (endocannabinoid, endovanilloid, opioid, monoaminergic).

An integrative, whole systems neuroscience approach is employed, combining preclinical and clinical behavioural studies with in vivo and ex vivo investigation of neurotransmitters, lipids (e.g. endocannabinoids), proteins or genes (e.g. cytokines, receptors, enzymes, signal transduction molecules, immediate early genes and transcription factors) throughout the nervous system. The laboratory places an emphasis on a translational, bench-to-bedside approach, with studies in both rodents and humans. This research, which is funded from a number of competitive sources, aims to make a significant contribution to the knowledge-base on chronic pain, stress-related psychiatric disorders and their interaction, and support the development of novel therapeutic agents for their treatment.

For publications list see:
http://www.nuigalway.ie/medicine-nursing-and-health-sciences/medicine/disciplines/pharmacology/stafflist/davidfinn/
and
https://www.ncbi.nlm.nih.gov/pubmed/?term=Finn+DP

Scroll to Top